Target intelligence / Profile preview

Rabbit hemorrhagic disease virus capsid protein VP60 (VP60)

Target
VP60
Molecular classification
Viral capsid protein [4, 11], Structural protein [1, 9]
01

Overview

The Rabbit Hemorrhagic Disease Virus (RHDV) capsid protein VP60 is the primary structural protein of the virus, forming an icosahedral shell that protects the viral genome [4, 11]. It plays a critical role in the viral life cycle by mediating attachment to host cells through interactions with histo-blood group antigens (HBGAs), which triggers viral entry via endocytosis [4, 11]. As the most prominent surface protein, VP60 is the major target for the host's immune response and is the central component of most RHDV vaccines, including inactivated, recombinant, and virus-like particle (VLP) formulations [2, 3, 5]. These vaccines function by inducing neutralizing antibodies that block the protein's ability to bind to host receptors, thereby preventing infection [10, 16]. VP60 is also essential for diagnostic applications, serving as a key antigen in serological assays and a target for molecular detection of the virus in clinical samples [1, 10].

Other names
Major capsid protein VP60 [1, 9]VP1 [14, 15]Capsid structural protein VP60 [6, 14]L1-like protein [4]
02

Mechanism of action

Induction of neutralizing antibodies that block viral attachment to host histo-blood group antigens (HBGAs) and prevent viral entry into host cells [10, 16].

03

Biological functions

Viral entry [4, 11]Viral assembly [2, 6]Genome packaging [4, 11]Receptor binding [4, 11]Induction of endocytosis [4, 7]
04

Disease associations

Rabbit Hemorrhagic Disease [8, 11]Infection [11, 13]Acute necrotizing hepatitis [11, 14]
05

Safety considerations

Antigenic variation between RHDV1 and RHDV2 [5, 13]Rapid viral evolution and recombination [13, 14]Lack of cross-protection between divergent strains [10, 13]
06

Interacting drugs

Filavac VHD K C+V [3, 16]

4 more in the full profile.

07

Biomarkers

Anti-VP60 IgG antibodies [2, 10]VP60 antigen [1, 10]Hemagglutination titer [10, 13]

Beyond the preview

Go deeper on Rabbit hemorrhagic disease virus capsid protein VP60 (VP60).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rabbit hemorrhagic disease virus capsid protein VP60 (VP60).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call